Cardiol Therapeutics Inc (NASDAQ:CRDL)
| 0.9401 Delayed Data As of 3:56pm ET |  -0.0287 / -2.96%Today’s Change | 0.45 Today|||52-Week Range 1.24 | +84.33% Year-to-Date |
Latest CRDL News | Press Releases
No recent news for Cardiol Therapeutics Inc.
Today’s Trading
| Previous close | 0.97 |
| Today’s open | 0.97 |
| Day’s range | 0.94 - 0.97 |
| Volume | 3,336 |
| Average volume (3 months) | 214,164 |
| Market cap | $60.5M |
Data as of 3:56pm ET, 12/06/2023
Growth & Valuation
| Earnings growth (last year) | +34.89% |
| Earnings growth (this year) | +7.95% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OCUPOcuphire Pharma Inc | -0.01 | -0.36% |
| SCYXSCYNEXIS Inc | -0.01 | -0.59% |
| TPSTTempest Therapeutics... | -0.13 | -4.01% |
| ---- |
Data as of 3:59pm ET, 12/06/2023
Financials
| Next reporting date | March 28, 2024 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$23.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Oakville, Ontario |
Forecasts
